Finance

Lists
Why is CAVA down 2.01%?
Dive Deeper
CAVA:NYSE
CAVA Group Inc
$52.56
-2.01%
(-1.08) 1D
$52.60
+0.08% (+0.040)
After hours
Closed: Oct 12, 4:00:04 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CAVA...
Open
$52.70
High
$53.00
Low
$50.67
Mkt. cap
6.14B
Avg. vol.
3.46M
Volume
0.00
52-wk high
$98.79
52-wk low
$43.41
Beta
1.80
Shares outstanding
116.81M
No. of employees
13K
Open
$52.70
High
$53.00
Low
$50.67
Mkt. cap
6.14B
Avg. vol.
3.46M
Volume
0.00
52-wk high
$98.79
52-wk low
$43.41
Beta
1.80
Shares outstanding
116.81M
No. of employees
13K
News stories
From web sources and news partners
About CAVA Group Inc
CEOBrett Schulman
Employees13.5K
Founded2006
Headquarters-
SectorRestaurant
Websitecava.com
Analyst ratings
Based on 22 analysts giving stock ratings to CAVA in the past 3 months
Strong buy
Buy
18
Hold
4
Sell
0
12-month forecast
Based on 22 Wall Street analysts offering 12 month price targets for CAVA in the last 3 months.
Highest
Current $52.56
$110.00 (+109.28%)
Average
$89.26 (+69.82%)
Lowest
$58.00 (+10.35%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jacob Aiken Phillips
Melius Research
Buy
Upgraded
$95.00
+80.7%
10/08/2026
John Ivankoe
J.P. Morgan
Buy
Maintained
$80.00
+52.2%
09/29/2026
Joe Feldman
Telsey Advisory
Buy
Maintained
$95.00
+80.7%
09/23/2026
Unknown Analyst
Seaport Global
Buy
Initiated
$58.00
+10.4%
09/15/2026
Eric Gonzalez
Seaport Global
Buy
Initiated
$58.00
+10.4%
09/15/2026
Logan Reich
RBC Capital
Buy
Maintained
$85.00
+61.7%
09/16/2026
Todd Brooks
StoneX
Buy
Maintained
$110.00
+109.3%
09/14/2026
Unknown Analyst
Robert W. Baird
Buy
Reiterated
$98.00
+86.5%
08/24/2026
Chris O`Cull
Robert W. Baird
Buy
Reiterated
$98.00
+86.5%
08/24/2026
Nick Setyan
Mizuho Securities
Hold
Maintained
$70.00
+33.2%
08/13/2026
Jim Sanderson
Northcoast Research
Hold
Upgraded
-
-
08/13/2026
Gregory Francfort
Guggenheim
Buy
Reiterated
$95.00
+80.7%
08/12/2026
Brian Vaccaro
Raymond James
Hold
Reiterated
-
-
08/12/2026
JP Wollam
Roth MKM
Buy
Reiterated
$95.00
+80.7%
08/12/2026
Danilo Gargiulo
Bernstein
Buy
Reiterated
$95.00
+80.7%
08/12/2026
Margaret-May Binshtok
Wolfe Research
Buy
Maintained
$82.00
+56%
08/11/2026
Jon Tower
Citi
Hold
Maintained
$79.00
+50.3%
08/11/2026
Dennis Geiger
UBS
Buy
Maintained
$90.00
+71.2%
08/12/2026
Brian Harbour
Morgan Stanley
Buy
Maintained
$90.00
+71.2%
08/12/2026
Brian Mullan
Piper Sandler
Buy
Maintained
$92.00
+75%
08/12/2026
Sara Senatore
Bank of America Securities
Buy
Reiterated
$107.00
+103.6%
08/13/2026
Sharon Zackfia
William Blair
Buy
Maintained
-
-
08/12/2026
Christopher Carril
KeyBanc
Buy
Maintained
$95.00
+80.7%
08/12/2026
Andrew Charles
TD Cowen
Buy
Maintained
$85.00
+61.7%
08/12/2026
Unknown Analyst
Freedom Capital Markets
Hold
Initiated
$95.00
+80.7%
06/30/2026
Sarang Vora
Telsey Advisory
Buy
Maintained
-
-
06/18/2026
Christine Dooley
Argus Research
Buy
Upgraded
$92.00
+75%
05/21/2026
Matt Curtis
D.A. Davidson
Hold
Maintained
$84.00
+59.8%
05/20/2026
Unknown Analyst
D.A. Davidson
Hold
Maintained
$84.00
+59.8%
05/20/2026
David Tarantino CFA
Robert W. Baird
Buy
Maintained
$98.00
+86.5%
05/20/2026
Jeff Bernstein
Barclays
Hold
Maintained
$74.00
+40.8%
05/20/2026
Unknown Analyst
Roth MKM
Buy
Initiated
$106.00
+101.7%
04/22/2026
Unknown Analyst
Raymond James
Hold
Reiterated
-
-
04/21/2026
Dana Telsey
Telsey Advisory
Buy
Maintained
$88.00
+67.4%
04/13/2026
Stephen J McManus
Exane BNP Paribas
Hold
Initiated
$91.00
+73.1%
03/30/2026
Greg Badishkanian
Wolfe Research
Buy
Initiated
$93.00
+76.9%
03/09/2026
Last report
Aug 11, 2026
Fiscal period
Q2 2026
$0.19 / $0.18
+3.13%beat
Revenue / Est. (USD)
368.44M / 359.36M
+2.52%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Oct 2025
Dec 2025
Apr 2026
Jul 2026
Revenue
292.24M
274.98M
438.27M
368.44M
Cost of goods sold
181.66M
178.79M
269.09M
225.97M
Cost of revenue
181.66M
178.79M
269.09M
225.97M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
31.50M
32.52M
51.59M
39.80M
Operating expense
92.28M
92.38M
141.21M
114.39M
Total operating expenses
273.94M
271.17M
410.30M
340.36M
Operating income
18.30M
3.82M
27.98M
28.08M
Other non operating income
-30.00K
-2.00K
700.00K
439.00K
EBT including unusual items
20.67M
6.08M
30.04M
30.58M
EBT excluding unusual items
21.84M
7.09M
32.76M
31.81M
Income tax expense
5.92M
1.16M
6.47M
7.56M
Effective tax rate
28.64%
19.05%
21.55%
24.73%
Other operating expenses
38.21M
36.84M
57.99M
46.89M
Net income
14.75M
4.92M
23.57M
23.02M
Net profit margin
5.05%
1.79%
5.38%
6.25%
Earnings per share
0.12
0.04
0.20
0.19
Interest and investment income
3.58M
3.27M
4.08M
3.29M
Interest expense
-
-
-
-
Net interest expenses
3.58M
3.27M
4.08M
3.29M
Depreciation and amortization charges
17.63M
18.41M
25.47M
20.97M
EBITDA
35.92M
22.22M
53.44M
49.04M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps